Transcriptional requirements for pro-cachectic gMDSC amplification

促恶病质 gMDSC 扩增的转录要求

• 批准号: 421955
• 负责人: Clemente Casares Javier
• 金额: $ 4.37万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-02-01 至 2022-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=421955&lang=en
• 关键词: Cancer Cachexia; Gmdscs; Transcription Factors

Cachexia or wasting consists of the progressive loss of fat, but most remarkably muscular mass, resulting in a loss of muscle and cardiorespiratory fitness. Several clinical studies suggest that the development of cachexia is associated with a very poor c

恶病质或消瘦包括脂肪的进行性损失，但最显著的是肌肉质量，导致肌肉和心肺功能的损失。一些临床研究表明恶病质的发展与非常差的c